BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Muscular Dystrophy Association 

National Headquarters
3300 E. Sunrise Drive
Tucson  Arizona  85718  U.S.A.
Phone: 800-344-4863 Fax:


SEARCH JOBS




Industry
Healthcare






 Company News
Muscular Dystrophy Association Awards Second "Bridge-To-Industry" Grant 12/12/2013 12:58:53 PM
Quintiles, Inc. (QTRN) Selected by Muscular Dystrophy Association to Develop U.S. Disease Registry 10/8/2013 10:06:16 AM
NicOx SA (COX.PA) Release: Pre-Clinical Results on Naproxcinod in Models of Muscular Dystrophy Presented at Muscular Dystrophy Association Scientific Conference 4/24/2013 10:23:45 AM
Fate Therapeutics Presents Preclinical Efficacy Data for WNT7A-Analog Program at Muscular Dystrophy Association 2013 Scientific Conference 4/22/2013 1:28:56 PM
Muscular Dystrophy Association: Scientific Conference to Focus on Therapy Development for Neuromuscular Diseases 4/22/2013 9:21:21 AM
StorageMart: Pinterest Campaign Supports Research for Spinal Muscular Atrophy 3/20/2013 2:47:25 PM
Muscular Dystrophy Association Release: Drug for Duchenne Muscular Dystrophy Successfully Completes Phase 1 Trial; Trial in Boys With DMD May be Next 10/11/2012 10:33:53 AM
Muscular Dystrophy Association Board Appoints Steven M. Derks President and Chief Executive Officer 9/18/2012 10:19:22 AM
U.S. Patent Office Issues Sixth Patent Covering "Zero-Footprint" Medical Image Viewers to Heart Imaging Technologies, LLC 5/1/2012 10:56:59 AM
Muscular Dystrophy Association Release: SMT C1100 for Duchenne Muscular Dystrophy Moves to Human Testing 4/24/2012 10:19:03 AM
123